Inicio › Linfoma difuso de células B grandes › Indiana
Ensayos clínicos de Linfoma difuso de células B grandes en Indiana
9 estudios sobre Linfoma difuso de células B grandes buscan participantes en Indiana.
Ciudades en Indiana
Texto oficial del estudio (inglés)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Saint Mary Medical Center, Hobart
- y 4 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06649812A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis
- Investigative Clinical Research of Indiana, Noblesville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06091865A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Fort Wayne Medical Oncology and Hematology ( Site 0149), Fort Wayne
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06717347Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
- IU Simon Comprehensive Cancer Center, Indianapolis
- Indiana Blood and Marrow Transplantation, Indianapolis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT06500273Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Indiana Blood and Marrow Transplantation, Indianapolis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT05826535Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jul 2026 · NCT05852717Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- Northwest Cancer Center - Main Campus, Crown Point
- Northwest Oncology LLC, Dyer
- Northwest Cancer Center - Hobart, Hobart
- y 5 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2025 · NCT05890352DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 abr 2023 · NCT04920617Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Goshen Center for Cancer Care, Goshen
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 ago 2022 · NCT04502394De ClinicalTrials.gov, datos obtenidos el 2 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.